EP3919048
AÐFERÐIR TIL MEÐFERÐAR Á BRISKRABBAMEINI MEÐ SAMSETNINGARMEÐFERÐUM SEM INNIHALDA LÍPÓSÓMAL-IRÍNÓTEKAN
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
12.6.2013EP published:
28.1.2026EP application number:
21171689.9
EP translation filed:
9.3.2026Grant published:
8.4.2026EPO information:
European Patent Register
Max expiry date:
11.6.2033Expiry date:
11.6.2026
Title in English:
METHODS FOR TREATING PANCREATIC CANCER USING COMBINATION THERAPIES COMPRISING LIPOSOMAL IRINOTECANLanguage of the patent:
English
Timeline
Today
12.6.2013EP application
28.1.2026EP Publication
9.3.2026Translation submitted
8.4.2026Registration published
11.6.2026Expires
Owner
Name:
Ipsen Biopharm Ltd.Address:
Ash Road, Wrexham Industrial Estate Wrexham LL13 9UF, GB
Inventor
Name:
BAYEVER, ElielAddress:
New York, US
Name:
DHINDSA, NavreetAddress:
Boston, US
Name:
FITZGERALD, Jonathan BasilAddress:
Arlington, US
Name:
LAIVINS, PeterAddress:
Scituate, US
Name:
MOYO, VictorAddress:
Ringoes, US
Name:
NIYIKIZA, CletAddress:
Gulph Mills, US
Name:
KIM, JaeyeonAddress:
Lexington, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201261659211 PDate:
13.6.2012Country:
US
Number:
201361784382 PDate:
14.3.2013Country:
US
Classification
Categories:
A61K 9/00, A61K 31/4745, A61K 31/513, A61K 31/517, A61P 35/00, A61K 9/127, A61K 31/519, A61K 45/06, A61P 1/18, A61P 9/00, A61P 43/00